Showing results (71-80 of 169) with videos related to

Sort By:
Pageof 17
Diabetes Care|October 14, 2011
Association of pretransplant glycemic control with posttransplant outcomes in diabetic kidney transplant recipientsMiklos Z Molnar, Edmund Huang, Junichi Hoshino, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 14, 2012
Association of pre-transplant erythropoiesis-stimulating agent responsiveness with post-transplant outcomesMiklos Z Molnar, Suphamai Bunnapradist, Edmund Huang, et al.
Diabetes|February 9, 2012
Glycemic control and cardiovascular mortality in hemodialysis patients with diabetes: a 6-year cohort studyJoni Ricks, Miklos Z Molnar, Csaba P Kovesdy, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 23, 2011
Glycemic control and survival in peritoneal dialysis patients with diabetes mellitusUyen Duong, Rajnish Mehrotra, Miklos Z Molnar, et al.
Molecular Pharmacology|January 27, 2004
The type 1 angiotensin II receptor tail affects receptor targeting, internalization, and membrane fusion propertiesBryan N Becker, Hui-fang Cheng, Timothy G Hammond, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 19, 2004
Rituximab as treatment for refractory kidney transplant rejectionYolanda T Becker, Bryan N Becker, John D Pirsch, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 18, 2011
The rationale, implementation, and effect of the Medicare CKD education benefitHenry N Young, Micah R Chan, Alex S Yevzlin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 29, 2002
Erythropoietin therapy may retard progression in chronic renal transplant dysfunctionBryan N Becker, Yolanda T Becker, Glen E Leverson, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 6, 2003
Clinical evaluation of heme iron polypeptide: sustaining a response to rHuEPO in hemodialysis patientsAllen R Nissenson, Jeffrey S Berns, Paul Sakiewicz, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 2, 2008
Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysisElani Streja, Csaba P Kovesdy, Sander Greenland, et al.
Pageof 17